Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.860
-0.060 (-3.12%)
May 14, 2025, 3:02 PM - Market open

Inovio Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
39.9265.8114.3146.3371.14250.73
Upgrade
Short-Term Investments
28.4528.3130.98206.67330.17160.91
Upgrade
Cash & Short-Term Investments
68.3694.11145.29253401.31411.64
Upgrade
Cash Growth
-35.27%-35.23%-42.57%-36.96%-2.51%359.76%
Upgrade
Receivables
1.311.22.4111.748.0319.06
Upgrade
Prepaid Expenses
2.222.525.4120.5139.14.8
Upgrade
Other Current Assets
---30-35.66
Upgrade
Total Current Assets
71.8997.83153.11315.24448.44471.17
Upgrade
Property, Plant & Equipment
11.0911.7714.4517.9629.0224.09
Upgrade
Long-Term Investments
2.311.612.782.013.914.89
Upgrade
Goodwill
---10.5110.5110.51
Upgrade
Other Intangible Assets
---2.132.633.15
Upgrade
Other Long-Term Assets
1.981.980.610.681.4325.96
Upgrade
Total Assets
87.27113.2170.95348.53495.94539.77
Upgrade
Accounts Payable
13.396.444.6521.0827.971.47
Upgrade
Accrued Expenses
1.8213.1318.6426.4230.5530.08
Upgrade
Current Portion of Long-Term Debt
--16.77---
Upgrade
Current Portion of Leases
2.582.52.412.82.62.33
Upgrade
Current Unearned Revenue
--0.112.564.627.58
Upgrade
Other Current Liabilities
9.5413.26-44-0.25
Upgrade
Total Current Liabilities
27.3335.3342.5796.8765.7441.71
Upgrade
Long-Term Debt
---16.6114.9618.66
Upgrade
Long-Term Leases
8.79.3711.0312.6615.4618.06
Upgrade
Long-Term Unearned Revenue
----0.060.12
Upgrade
Long-Term Deferred Tax Liabilities
---0.030.030.03
Upgrade
Other Long-Term Liabilities
----0.010.06
Upgrade
Total Liabilities
36.0244.6953.6126.1796.2778.63
Upgrade
Common Stock
0.040.040.020.020.220.19
Upgrade
Additional Paid-In Capital
1,8021,7991,7411,7111,6101,367
Upgrade
Retained Earnings
-1,750-1,730-1,623-1,488-1,210-906.2
Upgrade
Comprehensive Income & Other
-0.66-0.68-0.66-0.7-0.28-0.26
Upgrade
Total Common Equity
51.2568.5117.35222.36399.67461.14
Upgrade
Shareholders' Equity
51.2568.5117.35222.36399.67461.14
Upgrade
Total Liabilities & Equity
87.27113.2170.95348.53495.94539.77
Upgrade
Total Debt
11.2711.8730.2132.0733.0239.05
Upgrade
Net Cash (Debt)
57.0982.25115.08220.92368.29372.59
Upgrade
Net Cash Growth
-38.07%-28.53%-47.91%-40.01%-1.16%-
Upgrade
Net Cash Per Share
1.843.035.1911.1121.1628.82
Upgrade
Filing Date Shares Outstanding
36.6736.6723.3721.6818.1217.3
Upgrade
Total Common Shares Outstanding
36.6736.122.7921.0918.1215.57
Upgrade
Working Capital
44.5762.5110.54218.37382.7429.46
Upgrade
Book Value Per Share
1.401.905.1510.5422.0629.62
Upgrade
Tangible Book Value
51.2568.5117.35209.72386.53447.48
Upgrade
Tangible Book Value Per Share
1.401.905.159.9421.3428.74
Upgrade
Machinery
-8.369.913.4920.5912.16
Upgrade
Leasehold Improvements
-11.7615.9215.815.815.18
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q